Abstract
GenoMed4All is building an open, federated data hub to explore new AI models and services for clinical support in blood disorders.
Haematological diseases comprise a large group of up to 450 disorders resulting from abnormalities of blood cells, lymphoid organs and coagulation factors, generally categorised as either oncological or non-oncological. Most have a genetic background, and they represent a significant public health challenge: haematological malignancies account for about 5% of cancers, most can cause chronic health problems, and many are life-threatening conditions. In 2016, the European Haematology Association (EHA) estimated the financial burden of blood disorders on European society to be approximately €22.5bn per year. Moreover, data scarcity remains a pressing issue: the number of available samples for blood disorders remains small and is characterised by a high level of fragmentation, which mostly stems from the sensitive nature of data.
GenoMed4All is the European response to this scenario: an EU-funded initiative to radically transform the way we approach diagnosis, prognosis and treatment in haematological diseases through the use of Artificial intelligence (AI).